Skip to content

Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.

Powered by THEMA

Current Report · Items 5.02 · 8-K/A

Celanese Corporation

CENYSEEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (d) Celanese Corporation (the “Company”) is filing this amendment to its Current Report on Form 8-K filed on April 20, 2026, which reported the election of Anne P. Noonan to the Board of Directors (the “Board”) of the Company.…

Filed Oct 20, 2026Accepted Oct 20, 2026, 4:27 PM EDTCIK 1306830Accession 0001306830-26-000124

View company →Permanent SEC source ↗

Company context

Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation is a Fortune 500 company that employed more than 11,000 employees worldwide as of December 31, 2025 with 2025 net sales of $9.5 billion.

Current securities

CENYSE · EQUITY · Current

Recent company filings

Registered securities in this filing

CELANESE CORPORATION · 8-K/A · Filed 2026-10-20

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $0.0001 per share

Symbol: CE
Exchange: NYSE
Classification: COMMON
Status: Current

Filing context

Context: c-2

Dimensions: us-gaap:StatementClassOfStockAxis

2.125% Senior Notes due 2027

Symbol: CE /27
Exchange: NYSE
Classification: DEBT

Filing context

Context: c-3

Dimensions: us-gaap:StatementClassOfStockAxis

0.625% Senior Notes due 2028

Symbol: CE /28
Exchange: NYSE
Classification: DEBT

Filing context

Context: c-4

Dimensions: us-gaap:StatementClassOfStockAxis

5.337% Senior Notes due 2029

Symbol: CE /29A
Exchange: NYSE
Classification: DEBT

Filing context

Context: c-5

Dimensions: us-gaap:StatementClassOfStockAxis

5.000% Senior Notes due 2031

Symbol: CE /31
Exchange: NYSE
Classification: DEBT

Filing context

Context: c-6

Dimensions: us-gaap:StatementClassOfStockAxis

Accession 000130683026000124 · 5 registered-security cover members

Read the exact SEC filing ↗

Disclosure sections

Items 5.02

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (d) Celanese Corporation (the “Company”) is filing this amendment to its Current Report on Form 8-K filed on April 20, 2026, which reported the election of Anne P. Noonan to the Board of Directors (the “Board”) of the Company. At the time of her election, the Board had not determined her appointments to any committees of the Board. On October 15, 2026, the Board appointed Ms. Noonan to its Compensation and Management Development Committee and its Nominating and Corporate Governance Committee, effective immediately.